Founded by two former Canva employees, Australian startup Human Health has raised $8.5 million, led by LocalGlobe, to expand its global presence and create solutions for women’s health and chronic diseases.
Human Health, based in Sydney, has announced the closing of an $8.5 million funding round to support its global expansion and improve its interactive platform. This platform helps patients manage their own health.
The funding round was led by LocalGlobe, its newest investor from the UK. Other participants included Airtree, Skip Capital, Aliavia, Scale Ventures, and notable angel investors like Arvind Rajan of Cricket Health, Eric Salameh, former CEO of Kantar, and David Shine of OIF.
A Platform That Puts Patients at the Heart of Healthcare
Human Health was founded in 2022 by Kate Lambrides and Georgia Fiedler, who both previously worked at Canva. The founders describe the platform as a “Precision Health OS” that helps patients understand and use their health data. Users can track symptoms, treatments, and daily habits, then share results with doctors in ready-to-use reports.
“Our mission is simple: to give everyone personalized healthcare,” says Lambrides. “Millions of patients get lost in the system of appointments and waiting lists, losing control of their health. We’re giving that control back with smart digital tools that keep them at the center of decisions.”
The platform currently serves over 200,000 patients in the US, UK, and Canada, with more than 20 million health interactions recorded, averaging over 40,000 each day. This makes it one of the fastest-growing self-care platforms worldwide.
Investment to Boost the Shift to Personalized Medicine
The new funding will help expand the platform’s reach in the US and UK, and develop AI for women’s health, respiratory diseases, chronic pain, and autoimmune diseases. The company also plans to create Human Evidence, allowing researchers to use anonymized patient data to speed up medical discoveries.
Julia Hawkins, General Partner at LocalGlobe, pointed out that Human Health is building the data infrastructure to enable a major shift in medicine where patients are at the center of understanding before treatment.
Last August, the company announced a partnership with Diag-Nose.io to develop AI-powered therapeutic analytics tools for respiratory diseases, strengthening its position among data-driven health technology firms.
“We want to put patients at the heart of medicine—at the center of care and research,” says Fiedler. “When data speaks to the human experience, we can create a health system that learns from patients, not just treats them.”
